We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Nu Skin (NUS) Readies for Q4 Earnings: Everything to Note
Read MoreHide Full Article
Nu Skin Enterprises, Inc. ((NUS - Free Report) ) is likely to register a top-and-bottom-line decrease from the respective year-ago fiscal quarter’s reading when it reports fourth-quarter 2022 earnings on Feb 15. The Zacks Consensus Estimate for quarterly revenues is pegged at $543.8 million, suggesting a decline of 19.3% from the prior-year fiscal quarter’s reported figure.
The Zacks Consensus Estimate for quarterly earnings has remained unchanged in the past 30 days at 53 cents per share. This indicates a drop of 52.3% from the figure reported in the prior-year fiscal quarter.
This beauty and wellness product company has a trailing four-quarter negative earnings surprise of 5.3%, on average. NUS delivered a negative earnings surprise of 39.7% in the last reported quarter.
Nu Skin Enterprises, Inc. Price, Consensus and EPS Surprise
Nu Skin has been battling macro headwinds, including prolonged pandemic-related disruptions in Mainland China, sluggishness in South Korea due to economic pressures and company price increases, continued inflation and unfavorable currency movements. For the fourth quarter, Nu Skin expects an unfavorable foreign currency impact of 8-10% on revenues. In the full-year 2022, NUS envisions an unfavorable foreign currency impact of 5-7% on revenues.
For the fourth quarter, Nu Skin expects revenues between $500 million and $550 million. This revenue projection suggests an 18-26% decline from the year-ago quarter’s reported level. The company expects adjusted earnings in the band of 40-60 cents a share for the quarter, down from the $1.11 reported in the year-ago period.
For the full-year 2022, management anticipates revenues in the band of $2.20-$2.25 billion, suggesting a 16-18% decline from the year-ago period’s reported figure. Management expects 2022 adjusted earnings in the range of $2.40-$2.60 per share, indicating a decline from adjusted earnings of $4.14 reported last year.
That being said, the company remains focused on Nu Vision 2025, which is based around key strategic imperatives like the EmpowerMe personalized beauty and wellness strategy with connected beauty devices, an affiliate-powered social commerce business model and the expansion of the digital platform. Efforts to empower sales leaders also bode well.
What the Zacks Model Unveils
Our proven model predicts an earnings beat for Nu Skin this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is the case here.
Nu Skin has a Zacks Rank #3 and an Earnings ESP of +11.32%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Other Stocks With the Favorable Combination
Here are some other companies worth considering as our model shows that these also have the right combination of elements to beat earnings this season.
The J. M. Smucker Co. (SJM - Free Report) has an Earnings ESP of +1.00% and a Zacks Rank #3. The Zacks Consensus Estimate for its third-quarter fiscal 2023 earnings is pegged at $2.14, calling for an 8.2% decline from the year-ago period figure. SJM has a trailing four-quarter earnings surprise of 18.5%, on average. You can see the complete list of today’s Zacks #1 Rank stocks here.
The consensus mark for The J. M. Smucker’s top line is pegged at $2.2 billion, suggesting growth of 7.8% from the prior-year quarter’s reported figure.
Freshpet, Inc. (FRPT - Free Report) is likely to register top-and-bottom-line growth when it reports fourth-quarter 2022 results. FRPT has an Earnings ESP of +2.04% and a Zacks Rank #3. The Zacks Consensus Estimate for Freshpet’s bottom line has remained unchanged at a loss of 8 cents in the past 30 days compared with a loss of 21 cents reported in the year-ago period.
FRPT has a trailing four-quarter negative earnings surprise of roughly 88%, on average. The consensus mark for Freshpet’s top line is pegged at $151.1 million, calling for growth of 30.4% from the prior-year quarter’s reported figure.
The Boston Beer Company (SAM - Free Report) has an Earnings ESP of +49.17% and a Zacks Rank of 3 at present. SAM is likely to register top and bottom-line growth when it reports the fourth-quarter 2022 numbers. The Zacks Consensus Estimate for its quarterly revenues is pegged at $402 million, which suggests growth of 15.5% from the figure reported in the prior-year quarter.
The Zacks Consensus Estimate for the quarterly EPS of 72 cents suggests a significant increase from the loss of 9 cents per share reported in the year-ago quarter. SAM delivered a negative earnings surprise of 52.1%, on average, in the trailing four quarters.
Image: Bigstock
Nu Skin (NUS) Readies for Q4 Earnings: Everything to Note
Nu Skin Enterprises, Inc. ((NUS - Free Report) ) is likely to register a top-and-bottom-line decrease from the respective year-ago fiscal quarter’s reading when it reports fourth-quarter 2022 earnings on Feb 15. The Zacks Consensus Estimate for quarterly revenues is pegged at $543.8 million, suggesting a decline of 19.3% from the prior-year fiscal quarter’s reported figure.
The Zacks Consensus Estimate for quarterly earnings has remained unchanged in the past 30 days at 53 cents per share. This indicates a drop of 52.3% from the figure reported in the prior-year fiscal quarter.
This beauty and wellness product company has a trailing four-quarter negative earnings surprise of 5.3%, on average. NUS delivered a negative earnings surprise of 39.7% in the last reported quarter.
Nu Skin Enterprises, Inc. Price, Consensus and EPS Surprise
Nu Skin Enterprises, Inc. price-consensus-eps-surprise-chart | Nu Skin Enterprises, Inc. Quote
Factors to Consider
Nu Skin has been battling macro headwinds, including prolonged pandemic-related disruptions in Mainland China, sluggishness in South Korea due to economic pressures and company price increases, continued inflation and unfavorable currency movements. For the fourth quarter, Nu Skin expects an unfavorable foreign currency impact of 8-10% on revenues. In the full-year 2022, NUS envisions an unfavorable foreign currency impact of 5-7% on revenues.
For the fourth quarter, Nu Skin expects revenues between $500 million and $550 million. This revenue projection suggests an 18-26% decline from the year-ago quarter’s reported level. The company expects adjusted earnings in the band of 40-60 cents a share for the quarter, down from the $1.11 reported in the year-ago period.
For the full-year 2022, management anticipates revenues in the band of $2.20-$2.25 billion, suggesting a 16-18% decline from the year-ago period’s reported figure. Management expects 2022 adjusted earnings in the range of $2.40-$2.60 per share, indicating a decline from adjusted earnings of $4.14 reported last year.
That being said, the company remains focused on Nu Vision 2025, which is based around key strategic imperatives like the EmpowerMe personalized beauty and wellness strategy with connected beauty devices, an affiliate-powered social commerce business model and the expansion of the digital platform. Efforts to empower sales leaders also bode well.
What the Zacks Model Unveils
Our proven model predicts an earnings beat for Nu Skin this time. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat, which is the case here.
Nu Skin has a Zacks Rank #3 and an Earnings ESP of +11.32%. You can uncover the best stocks to buy or sell before they’re reported with our Earnings ESP Filter.
Other Stocks With the Favorable Combination
Here are some other companies worth considering as our model shows that these also have the right combination of elements to beat earnings this season.
The J. M. Smucker Co. (SJM - Free Report) has an Earnings ESP of +1.00% and a Zacks Rank #3. The Zacks Consensus Estimate for its third-quarter fiscal 2023 earnings is pegged at $2.14, calling for an 8.2% decline from the year-ago period figure. SJM has a trailing four-quarter earnings surprise of 18.5%, on average. You can see the complete list of today’s Zacks #1 Rank stocks here.
The consensus mark for The J. M. Smucker’s top line is pegged at $2.2 billion, suggesting growth of 7.8% from the prior-year quarter’s reported figure.
Freshpet, Inc. (FRPT - Free Report) is likely to register top-and-bottom-line growth when it reports fourth-quarter 2022 results. FRPT has an Earnings ESP of +2.04% and a Zacks Rank #3. The Zacks Consensus Estimate for Freshpet’s bottom line has remained unchanged at a loss of 8 cents in the past 30 days compared with a loss of 21 cents reported in the year-ago period.
FRPT has a trailing four-quarter negative earnings surprise of roughly 88%, on average. The consensus mark for Freshpet’s top line is pegged at $151.1 million, calling for growth of 30.4% from the prior-year quarter’s reported figure.
The Boston Beer Company (SAM - Free Report) has an Earnings ESP of +49.17% and a Zacks Rank of 3 at present. SAM is likely to register top and bottom-line growth when it reports the fourth-quarter 2022 numbers. The Zacks Consensus Estimate for its quarterly revenues is pegged at $402 million, which suggests growth of 15.5% from the figure reported in the prior-year quarter.
The Zacks Consensus Estimate for the quarterly EPS of 72 cents suggests a significant increase from the loss of 9 cents per share reported in the year-ago quarter. SAM delivered a negative earnings surprise of 52.1%, on average, in the trailing four quarters.
Stay on top of upcoming earnings announcements with the Zacks Earnings Calendar.